[89Zr]Zr-N-sucDf-NNV003

N/A

Report date: 2025/11/05 17:48:44

Base Information

Drug Name[89Zr]Zr-N-sucDf-NNV003

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionAnti-Leukocyte antigen CD37

TargetsLeukocyte antigen CD37

Therapy Area/IndicationsLymphoma, B-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlandsNorway

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNordic Nanovector Asa University Medical Center Groningen

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Medical Center Groningen Nordic Nanovector Asa

Inactive CompaniesN/A

Active IndicationsLymphoma, B-Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A